Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, Guy's Hospital, London, UK.
Hematol Oncol Clin North Am. 2011 Apr;25(2):261-75, vii. doi: 10.1016/j.hoc.2011.01.008.
This article reviews pregnancy outcome in women diagnosed with a myeloproliferative neoplasm (MPN), and discusses possible risk markers and the pathogenesis of poor pregnancy outcome. An outline of the key factors regarding the diagnosis and management of MPN in women of reproductive potential is followed by a description of the authors' management strategy for standard and high-risk pregnancy in MPN patients.
本文综述了诊断为骨髓增殖性肿瘤（MPN）的女性的妊娠结局，并讨论了可能的不良妊娠结局风险标志物和发病机制。本文首先概述了与生育期女性 MPN 的诊断和管理相关的关键因素，然后描述了作者对 MPN 患者标准和高危妊娠的管理策略。
